Clinical Trials Directory

Trials / Completed

CompletedNCT02713581

IgG Dependent Monocyte Activation in Proximal Venous Thromboembolism

Status
Completed
Phase
Study type
Observational
Enrollment
34 (actual)
Sponsor
Centre Hospitalier Universitaire de Nīmes · Academic / Other
Sex
Female
Age
18 Years – 50 Years
Healthy volunteers
Accepted

Summary

The primary objective of this study is to search for, in vitro, elements associated with IgG-dependent monocyte activation (signaling pathway activation, expression of pro-coagulant and pro-inflammatory factors) and to describe their prevalence in female patients with a history of proximal venous thromboembolism (proximal deep vein thrombosis or pulmonary embolism) compared to control women.

Detailed description

The secondary objectives of this study include to compare the IgG-dependent monocyte activation profiles as a function of laboratory thrombophilia parameters. Essentially: Is IgG-dependent cell activation associated with the presence of anti-phospholipid antibodies (or their subtypes?), or do these profiles indicate something beyond the nosology of anti-phospholipid syndrome?

Conditions

Interventions

TypeNameDescription
BIOLOGICALBlood samplingVenous blood will be sampled for laboratory analyses (see outcomes).

Timeline

Start date
2017-01-03
Primary completion
2019-01-03
Completion
2020-06-23
First posted
2016-03-18
Last updated
2020-06-30

Locations

2 sites across 1 country: France

Source: ClinicalTrials.gov record NCT02713581. Inclusion in this directory is not an endorsement.